How Bad is COVID-19 Hurting Orthopedic Companies?

Orthopedic firms fight for stability during the pandemic.

The orthopedics market has been on a wild ride since the beginning of the pandemic. Shutdowns and uncertainty with elective procedures, which include but are not limited to orthopedics, have put a lot of twists and turns in the market. Companies in the space have seen hits to revenue and have had to modify plans to make it through this fluid market.

Rewind the clock to April of 2020. American Academy of Orthopedic Surgeons (AAOS) issued guidance that would set the tone for orthopedic procedures until this day. The organization gave guidance that suggested every locality should make its own decisions based on the availability of resources and personnel.

By Omar Ford | MD+DI

Image Credit: Alexandr Mitiuc / Adobe


About Peter Coffaro 487 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 25 years of progressive management success within the medical device industry. Recognized by the World Journal of Orthopedics, Exponential Healthtech, and as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager, Distributor, and Vice President. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy, and Stryker. He is also the founder of OrthoFeed: a popular blog that covers digital orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing, and professional education. Peter holds a B.S. degree in Biology and Chemistry from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.